IFNAR1 and infection: Early IFNAR blockade was sufficient to reduce lung bacterial burden at 20 days after infection in C3HeB/FeJ mice, and protection was even more pronounced at day 26 (Fig. 8 f), similar to previous observations when anti-IFNAR was administered throughout infection (Moreira-Teixeira et al., 2020a).